Human keratinocytes restrict chikungunya virus replication at a post-fusion step (Q40178529)

18 September 2017

Human keratinocytes restrict chikungunya virus replication at a post-fusion step (English)

1 reference

18 September 2017

0 references

1 reference

1 reference

5

1 reference

18 September 2017

9

1 reference

18 September 2017

10

1 reference

18 September 2017

Graham Simmons

6

0 references

Rodolphe Hamel

series ordinal

2

object named as

Rodolphe Hamel

1 reference

18 September 2017

8

Philippe Desprès

1 reference

18 September 2017

1

Eric Bernard

1 reference

18 September 2017

7

Nathalie Chazal

1 reference

18 September 2017

Aymeric Neyret

3

1 reference

PubMed ID

25496825

18 September 2017

Peeraya Ekchariyawat

series ordinal

4

1 reference

PubMed ID

25496825

18 September 2017

language of work or name

English

0 references

publication date

8 December 2014

1 reference

18 September 2017

1 reference

18 September 2017

476

1 reference

18 September 2017

1-10

1 reference

The selectivity of protein kinase inhibitors: a further update

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Human papillomaviruses and the interferon response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Role of skin immune cells on the host susceptibility to mosquito-borne viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Most alphaviruses share a conserved epitopic region on their nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Interferon-λ in the context of viral infections: production, response and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Continuous high-titer HIV-1 vector production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Construction of an infectious Chikungunya virus cDNA clone and stable insertion of mCherry reporter genes at two different sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Keratinocytes are cell targets of West Nile virus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Induction of a peptide with activity against a broad spectrum of pathogens in the Aedes aegypti salivary gland, following Infection with Dengue Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Skin immune sentinels in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Diverse intracellular pathogens activate type III interferon expression from peroxisomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Human muscle satellite cells as targets of Chikungunya virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Dengue virus type 2: replication and tropisms in orally infected Aedes aegypti mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Biology and pathogenesis of chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Triggering the interferon antiviral response through an IKK-related pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Replication cycle of chikungunya: a re-emerging arbovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Characterization of reemerging chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Deciphering the differential response of two human fibroblast cell lines following Chikungunya virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Chikungunya: a risk for Mediterranean countries?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Orally co-Infected Aedes albopictus from La Reunion Island, Indian Ocean, can deliver both dengue and chikungunya infectious viral particles in their saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

In vivo imaging of chikungunya virus in mice and Aedes mosquitoes using a Renilla luciferase clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.11.013

10.1016/J.VIROL.2014.11.013

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

25496825